NewAmsterdam Pharma (NAMS) Assets (2021 - 2026)
NewAmsterdam Pharma (NAMS) posted Assets of $704.45 million for Q2 2026, down 13.6% from $815.11 million a year earlier and down 3.8% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, NewAmsterdam Pharma's Assets came in at $769.28 million, down 11.0% from FY2024.
- Annual Assets shows a four-year compound annual growth rate of 81.6% (FY2021 to FY2025).
- In prior years, NewAmsterdam Pharma's Assets was $864.62 million in FY2024 (+149.1%), $347.1 million in FY2023 (-27.5%), $478.5 million in FY2022 (+576.4%) and $70.75 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Assets since Q3 2024.
- On a year-over-year basis, Assets has declined in each of the last three quarters, with growth averaging 49.0% over the last seven quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q4 2022, with growth of 693.0%; the weakest was Q4 2023, with a decline of 36.0%.
- According to Business Quant data, Assets for the three prior quarters was $732.64 million (Q1 2026), $769.28 million (Q4 2025) and $786.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.59 Bn | 1,104.17 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 616.92 Bn | 535.45 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 501.52 Bn | 474.63 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 367.36 Bn | 321.74 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.93 Bn | 261.92 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 236.40 Bn | 191.80 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.72 Bn | 164.92 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn | 201.13 Bn |
| 10 | NewAmsterdam Pharma | 2.64 Bn | 34.68 Mn | - | 704.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 704.45 Mn |
| Mar 31, 2026 | 732.64 Mn |
| Dec 31, 2025 | 769.28 Mn |
| Sep 30, 2025 | 786.43 Mn |
| Jun 30, 2025 | 815.11 Mn |
| Mar 31, 2025 | 818.41 Mn |
| Dec 31, 2024 | 864.62 Mn |
| Sep 30, 2024 | 439.19 Mn |
| Jun 30, 2024 | 446.69 Mn |
| Mar 31, 2024 | 488.46 Mn |
| Dec 31, 2023 | 347.10 Mn |
| Jun 30, 2023 | 511.99 Mn |
| Dec 31, 2022 | 566.71 Mn |
| Jun 30, 2022 | 608.98 Mn |
| Dec 31, 2021 | 67.70 Mn |
API Access
NewAmsterdam Pharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();